We found that CDKN1A (p21), a transcriptional target of KLF6, was upregulated by both LCAC-16:0 and baseline plasma of non-HCC patients (Fig. 6A, Fig. S4A and S4B, Supporting Information Fig. S6A and B). Here, CDKN1A is linked to hepatocellular carcinoma.